Altimmune Inc
ALT
Altimmune Inc News & Analysis
stocks
2 companies poised to capitalize on the rise of GLP-1 drugs
Why Pfizer and Roche look like top choices for investors in the war to tip the scales.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,720.50 | 116.10 | -1.31% |
| CAC 40 | 8,080.74 | 66.09 | -0.81% |
| DAX 40 | 25,463.81 | 272.43 | -1.06% |
| Dow JONES (US) | 49,097.06 | 1,101.11 | -2.19% |
| FTSE 100 | 10,452.68 | 98.49 | -0.93% |
| HKSE | 22,841.62 | 453.13 | -1.95% |
| NASDAQ | 23,879.20 | 550.69 | -2.25% |
| Nikkei 225 | 58,215.98 | 1,228.23 | -2.07% |
| NZX 50 Index | 14,129.92 | 117.33 | -0.82% |
| S&P 500 | 7,175.83 | 147.80 | -2.02% |
| S&P/ASX 200 | 8,617.30 | 113.10 | -1.30% |
| SSE Composite Index | 3,577.62 | 10.21 | -0.28% |